X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (7366) 7366
Publication (728) 728
Book Review (49) 49
Book Chapter (23) 23
Dissertation (19) 19
Conference Proceeding (8) 8
Book / eBook (7) 7
Magazine Article (5) 5
Paper (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
animals (6227) 6227
rats (5450) 5450
rats, zucker (4376) 4376
male (3932) 3932
index medicus (2230) 2230
obesity (1883) 1883
endocrinology & metabolism (1611) 1611
obesity - metabolism (1507) 1507
female (1480) 1480
zucker rats (1276) 1276
humans (1274) 1274
mice (1145) 1145
obese zucker rats (1122) 1122
insulin resistance (1113) 1113
physiology (1053) 1053
obesity - physiopathology (998) 998
insulin (966) 966
insulin - blood (906) 906
disease models, animal (854) 854
blood glucose - metabolism (827) 827
diabetes (789) 789
insulin-resistance (754) 754
biochemistry & molecular biology (744) 744
pharmacology & pharmacy (734) 734
obesity - genetics (726) 726
body weight (725) 725
glucose (712) 712
rats, sprague-dawley (677) 677
liver - metabolism (637) 637
physiological aspects (632) 632
nutrition & dietetics (630) 630
expression (610) 610
metabolism (578) 578
leptin (556) 556
rats, wistar (554) 554
glucose - metabolism (547) 547
insulin - metabolism (521) 521
type 2 diabetes (506) 506
oxidative stress (495) 495
body weight - drug effects (481) 481
neurosciences (479) 479
research (457) 457
rodents (456) 456
gene-expression (454) 454
metabolic syndrome (453) 453
skeletal-muscle (442) 442
diet (440) 440
zucker rat (428) 428
hypoglycemic agents - pharmacology (426) 426
diabetes mellitus, type 2 - metabolism (416) 416
hypertension (413) 413
adipose tissue - metabolism (411) 411
food-intake (411) 411
adipose-tissue (405) 405
time factors (393) 393
muscle, skeletal - metabolism (392) 392
insulin - pharmacology (390) 390
liver (382) 382
obesity - pathology (369) 369
rna, messenger - metabolism (365) 365
obesity - complications (359) 359
dose-response relationship, drug (344) 344
peripheral vascular disease (343) 343
cell biology (338) 338
gene expression (334) 334
glucose tolerance test (331) 331
eating - drug effects (330) 330
triglycerides - blood (324) 324
article (322) 322
body-weight (322) 322
cells, cultured (316) 316
blood glucose - analysis (314) 314
insulin resistance - physiology (311) 311
obesity - blood (303) 303
obesity - drug therapy (297) 297
brain (291) 291
mice, inbred c57bl (291) 291
diabetes mellitus, type 2 - drug therapy (285) 285
lipid metabolism (283) 283
liver - drug effects (280) 280
medicine, research & experimental (269) 269
in-vivo (268) 268
diabetes mellitus, type 2 - physiopathology (266) 266
messenger-rna (265) 265
hypothalamus (263) 263
cardiac & cardiovascular systems (262) 262
dextrose (256) 256
resistance (253) 253
exercise (248) 248
phosphorylation (248) 248
analysis (246) 246
health aspects (246) 246
diabetes mellitus (243) 243
food intake (242) 242
hyperglycemia (241) 241
blood-pressure (240) 240
kinetics (238) 238
receptor (238) 238
diabetes mellitus, experimental - metabolism (236) 236
inflammation (233) 233
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Gerstein Science - Stacks (2) 2
New College (Ivey) - Stacks (2) 2
Robarts - Stacks (2) 2
Collection Dvlpm't (Acquisitions) - Vendor file (1) 1
St. Michael's College (John M. Kelly) - 2nd Floor (1) 1
UofT at Mississauga - Stacks (1) 1
UofT at Scarborough - Stacks (1) 1
Victoria University E.J. Pratt - Stacks (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (7297) 7297
French (37) 37
Japanese (29) 29
German (14) 14
Korean (14) 14
Spanish (12) 12
Chinese (7) 7
Polish (2) 2
Portuguese (2) 2
Russian (2) 2
Croatian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Diabetologia, ISSN 0012-186X, 09/2010, Volume 53, Issue 9, pp. 2008 - 2019
Reductions in peroxisome proliferator-activated receptor gamma, coactivator 1 alpha (PGC-1α) levels have been associated with the skeletal muscle insulin... 
Fatty acid oxidation | AS160 | Human Physiology | Metabolic Diseases | Diacylglycerol | Internal Medicine | Muscle fibres | Mitochondria | Medicine & Public Health | Triacylglycerol | Akt2 | Ceramide | FAT | GLUT4 | FATTY-ACID TRANSPORT | INCREASED EXPRESSION | MITOCHONDRIAL BIOGENESIS | ROSIGLITAZONE TREATMENT | PALMITATE OXIDATION | GLUT-4 PROTEIN | EXERCISE | MESSENGER-RNA | IN-VIVO | ENDOCRINOLOGY & METABOLISM | GENE-EXPRESSION | Insulin - pharmacology | RNA-Binding Proteins - genetics | Glucose Transporter Type 4 - genetics | Glucose Transporter Type 4 - metabolism | Rats | Male | Muscle, Skeletal - metabolism | Transcription Factors - genetics | Thinness - metabolism | Blotting, Western | Obesity - metabolism | Rats, Zucker | Transcription Factors - metabolism | Animals | Signal Transduction - drug effects | Muscle, Skeletal - drug effects | Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha | Lipid Metabolism - drug effects | Oxidation-Reduction - drug effects | Glucose - metabolism | Phosphorylation - drug effects | Fatty Acids - metabolism | RNA-Binding Proteins - metabolism | Obesity | Molecular genetics | Animal genetic engineering | Triglycerides | Mitochondrial DNA | Biosynthesis | Glucose | Insulin | Fatty acids | Dextrose | Messenger RNA | Physiological aspects | Insulin resistance | RNA | Muscles | Glucose metabolism | Genetic engineering
Journal Article
Diabetes, ISSN 0012-1797, 11/2008, Volume 57, Issue 11, pp. 2977 - 2991
Journal Article
Journal Article
Circulation, ISSN 0009-7322, 05/2002, Volume 105, Issue 19, pp. 2296 - 2302
Background-Pioglitazone and rosiglitazone, thiazolidinedione peroxisome proliferator-activated receptor-gamma (PPAR-gamma) activators, reduce blood pressure... 
Hypertension | Inflammation | Remodeling | Muscle, smooth | Arteries | MIGRATION | remodeling | THIAZOLIDINEDIONE | CARDIAC & CARDIOVASCULAR SYSTEMS | muscle, smooth | ZUCKER FATTY RATS | arteries | TYPE-1 RECEPTOR | INSULIN | inflammation | GENE-EXPRESSION | PPAR-GAMMA | PERIPHERAL VASCULAR DISEASE | ESSENTIAL-HYPERTENSION | ROSIGLITAZONE | HEMATOLOGY | hypertension | SMOOTH-MUSCLE CELLS | Inflammation - chemically induced | Receptors, Angiotensin - metabolism | Angiotensin II - administration & dosage | Body Weight - drug effects | Endothelium, Vascular - drug effects | Male | Thiazoles - administration & dosage | Inflammation - metabolism | Inflammation - drug therapy | Platelet Endothelial Cell Adhesion Molecule-1 - metabolism | Injections, Subcutaneous | Lipids - blood | DNA - biosynthesis | Blood Pressure - drug effects | Vasoconstrictor Agents - pharmacology | Vasodilator Agents - pharmacology | Drug Administration Schedule | Pioglitazone | Aldosterone - blood | Rats | Cell Cycle Proteins - biosynthesis | Renin - blood | Rats, Sprague-Dawley | Blood Vessels - cytology | Cell Division - drug effects | Transcription Factors - metabolism | Collagen - metabolism | Animals | Endothelium, Vascular - metabolism | NF-kappa B - biosynthesis | Blood Vessels - drug effects | Rosiglitazone | Blood Vessels - physiology | In Vitro Techniques | Vascular Cell Adhesion Molecule-1 - metabolism | Thiazolidinediones | Receptors, Cytoplasmic and Nuclear - metabolism
Journal Article
American Journal of Physiology - Renal Physiology, ISSN 0363-6127, 06/2012, Volume 302, Issue 12, pp. F1606 - F1615
Journal Article
Journal of Nutrition, ISSN 0022-3166, 08/2009, Volume 139, Issue 8, pp. 1495 - 1501
Journal Article
Journal Article
Clinical and Experimental Pharmacology and Physiology, ISSN 0305-1870, 12/2017, Volume 44, Issue 12, pp. 1263 - 1271
Journal Article
Journal of Lipid Research, ISSN 0022-2275, 04/2010, Volume 51, Issue 4, pp. 771 - 784
The farnesoid X receptor (FXR) is a bile acid activated nuclear receptor. Zucker (fa/fa) rats, harboring a loss of function mutation of the leptin receptor,... 
RESPONSE ELEMENT | TYROSINE PHOSPHORYLATION | METABOLISM | LINKING OBESITY | BIOCHEMISTRY & MOLECULAR BIOLOGY | DISEASE | ANIMAL-MODELS | FARNESOID-X-RECEPTOR | NONALCOHOLIC STEATOHEPATITIS | MECHANISMS | AGONISTS | Liver - pathology | Fatty Liver - pathology | Male | Muscle, Skeletal - metabolism | Insulin Receptor Substrate Proteins - metabolism | RNA, Messenger - metabolism | Thiazolidinediones - administration & dosage | Obesity - blood | Thiazolidinediones - therapeutic use | Hypoglycemic Agents - administration & dosage | Liver - drug effects | Time Factors | Lipids - blood | Muscle, Skeletal - drug effects | Chenodeoxycholic Acid - therapeutic use | Lipid Metabolism - genetics | Phosphorylation - drug effects | Drug Therapy, Combination | Disease Models, Animal | Hypoglycemic Agents - therapeutic use | Fatty Liver - blood | Obesity - complications | Liver - metabolism | Fatty Liver - prevention & control | Insulin Resistance | Rats | Chenodeoxycholic Acid - administration & dosage | Receptors, Cytoplasmic and Nuclear - agonists | Receptors, Cytoplasmic and Nuclear - genetics | Random Allocation | Chenodeoxycholic Acid - analogs & derivatives | Gene Expression Regulation - drug effects | Rats, Zucker | Animals | Hypolipidemic Agents - administration & dosage | Lipid Metabolism - drug effects | Hypolipidemic Agents - therapeutic use | Receptors, Cytoplasmic and Nuclear - metabolism
Journal Article
Journal Article